세계의 주사 표적치료 시장 보고서(2025년)

Injectable targeted therapy involves medications administered through injection that precisely target specific proteins or cells responsible for a disease. This approach aims to treat conditions such as cancer more effectively while minimizing damage to healthy tissues compared to conventional treatments.

The primary types of injectable targeted therapy are monoclonal antibodies, small molecules, immunotoxins, and others. Monoclonal antibodies are laboratory-engineered antibodies designed to bind specifically to target proteins on diseased cells. The primary mechanisms of action include targeted inhibition of signal transduction pathways, targeted delivery of cytotoxic agents, and immunomodulation. These therapies are commonly administered via intravenous, subcutaneous, or intramuscular routes. They are applied across diverse fields such as oncology, cardiometabolism, immunology, infectious diseases, neuroscience, ophthalmology, and others, serving end users including hospitals, specialty clinics, and research laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The injectable targeted therapy market research report is one of a series of new reports from The Business Research Company that provides injectable targeted therapy market statistics, including injectable targeted therapy industry global market size, regional shares, competitors with an injectable targeted therapy market share, detailed injectable targeted therapy market segments, market trends and opportunities, and any further data you may need to thrive in the injectable targeted therapy industry. This injectable targeted therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The injectable targeted therapy market size has grown rapidly in recent years. It will grow from $57.97 billion in 2024 to $64.22 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth during the historic period was driven by the increasing number of clinical trials for injectable targeted therapies, rising focus on precision oncology and immunotherapy, expanding supportive reimbursement policies for biologic therapies, growing patient preference for minimally invasive treatment options, and increasing regulatory approvals for new injectable targeted therapies.

The injectable targeted therapy market size is expected to see rapid growth in the next few years. It will grow to $95.46 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth during the forecast period is fueled by rising prevalence of chronic and rare diseases, growing demand for personalized medicine, wider adoption of biologics over conventional therapies, increasing awareness of targeted therapies among healthcare professionals, and higher investments in biotechnology and pharmaceutical research and development. The primary trends in the forecast period include technology driven innovations in monoclonal antibodies, integration of digital health platforms for patient monitoring, developments in antibody-drug conjugates, advancements in bispecific antibodies for cancer treatment, and progress in personalized medicine approaches.

The growing demand for personalized medicine is expected to drive the expansion of the injectable targeted therapy market. Personalized medicine is an approach that tailors prevention, diagnosis, and treatment based on an individual's genetic, environmental, and lifestyle factors. This shift toward personalized medicine is largely fueled by advances in genomics, which allow for a deeper understanding of genetic variations and enable more precise treatments that enhance patient outcomes while reducing the trial-and-error approach in therapies. Injectable targeted therapy supports personalized medicine by delivering treatments that specifically target a patient's unique molecular or genetic disease profile, improving efficacy and minimizing side effects. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. These new approvals included seven cancer drugs and three for other diseases. As a result, the increasing demand for personalized treatments is driving growth in the injectable targeted therapy market.

Leading companies in the injectable targeted therapy market are focusing on creating innovative solutions such as subcutaneous injections to improve drug delivery, enhance patient compliance, and target specific disease pathways more effectively. Subcutaneous injections involve delivering medication just beneath the skin into the fatty tissue, where it is gradually absorbed into the bloodstream. For instance, in August 2025, Eisai Co., Ltd., a Japan-based pharmaceutical company, partnered with Biogen Inc., a US-based biotechnology company, and received FDA approval for LEQEMBI IQLIK, a treatment for early Alzheimer's disease. This once-weekly subcutaneous injection is designed for maintenance treatment after an initial intravenous therapy, allowing patients to self-administer at home. The treatment works by targeting and clearing amyloid beta plaques and protofibrils, which contribute to Alzheimer's progression. By reducing treatment time and systemic side effects compared to intravenous infusions, the formulation offers patients greater independence and reduces the need for frequent visits to infusion centers.

In September 2025, Novartis AG, a pharmaceutical company based in Switzerland, acquired Tourmaline Bio Inc. for an undisclosed amount. This acquisition allows Novartis to enhance and diversify its cardiovascular portfolio with pacibekitug, a novel anti-inflammatory therapy that targets IL-6 to address residual inflammatory risk in atherosclerotic cardiovascular disease. With this addition, Novartis positions itself at the forefront of inflammation-driven cardiovascular treatments and aims to capture significant growth opportunities in this market. Tourmaline Bio Inc., a US-based biotechnology company, specializes in injectable targeted therapies.

Major players in the injectable targeted therapy market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Novartis AG, AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Eisai Co. Ltd., Genentech Inc., Beigene Ltd., Agenus Inc., and Xilio Therapeutics Inc.

North America was the largest region in the injectable targeted therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in injectable targeted therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the injectable targeted therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The injectable targeted therapy market consists of sales of bispecific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Injectable Targeted Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on injectable targeted therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for injectable targeted therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injectable targeted therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Monoclonal Antibodies; Small-Molecules; Immunotoxins; Other Types
• 2) By Mechanism Of Action: Targeted Inhibition of Signal Transduction Pathways; Targeted Delivery Of Cytotoxic Agents; Immunomodulation
• 3) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular
• 4) By Application: Oncology; Cardiometabolism; Immunology; Infectious Diseases; Neuroscience; Ophthalmology; Other Applications
• 5) By End User: Hospitals; Specialty Clinics; Research Laboratories
• Subsegments:
• 1) By Monoclonal Antibodies: Fully Human Antibodies; Humanized Antibodies; Chimeric Antibodies
• 2) By Small-Molecules: Tyrosine Kinase Inhibitors; Proteasome Inhibitors; Mtor Inhibitors
• 3) By Immunotoxins: Recombinant Immunotoxins; Chemical Conjugates; Fusion Proteins
• 4) By Other Types: Antibody-Drug Conjugates; Bispecific Antibodies; Peptide-Based Therapeutics
• Companies Mentioned: Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Novartis AG; AstraZeneca plc; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company; Amgen Inc.; Gilead Sciences Inc.; Regeneron Pharmaceuticals Inc.; Biogen Inc.; Eisai Co. Ltd.; Genentech Inc.; Beigene Ltd.; Agenus Inc.; Xilio Therapeutics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Injectable Targeted Therapy Market Characteristics

3. Injectable Targeted Therapy Market Trends And Strategies

4. Injectable Targeted Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Injectable Targeted Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Injectable Targeted Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Injectable Targeted Therapy Market Growth Rate Analysis
• 5.4. Global Injectable Targeted Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Injectable Targeted Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Injectable Targeted Therapy Total Addressable Market (TAM)

6. Injectable Targeted Therapy Market Segmentation

• 6.1. Global Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Small-Molecules
• Immunotoxins
• Other Types
• 6.2. Global Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Inhibition Of Signal Transduction Pathways
• Targeted Delivery Of Cytotoxic Agents
• Immunomodulation
• 6.3. Global Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous
• Subcutaneous
• Intramuscular
• 6.4. Global Injectable Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiometabolism
• Immunology
• Infectious Diseases
• Neuroscience
• Ophthalmology
• Other Applications
• 6.5. Global Injectable Targeted Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Research Laboratories
• 6.6. Global Injectable Targeted Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fully Human Antibodies
• Humanized Antibodies
• Chimeric Antibodies
• 6.7. Global Injectable Targeted Therapy Market, Sub-Segmentation Of Small-Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tyrosine Kinase Inhibitors
• Proteasome Inhibitors
• Mtor Inhibitors
• 6.8. Global Injectable Targeted Therapy Market, Sub-Segmentation Of Immunotoxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Immunotoxins
• Chemical Conjugates
• Fusion Proteins
• 6.9. Global Injectable Targeted Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibody-Drug Conjugates
• Bispecific Antibodies
• Peptide-Based Therapeutics

7. Injectable Targeted Therapy Market Regional And Country Analysis

• 7.1. Global Injectable Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Injectable Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Injectable Targeted Therapy Market

• 8.1. Asia-Pacific Injectable Targeted Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Injectable Targeted Therapy Market

• 9.1. China Injectable Targeted Therapy Market Overview
• 9.2. China Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Injectable Targeted Therapy Market

• 10.1. India Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Injectable Targeted Therapy Market

• 11.1. Japan Injectable Targeted Therapy Market Overview
• 11.2. Japan Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Injectable Targeted Therapy Market

• 12.1. Australia Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Injectable Targeted Therapy Market

• 13.1. Indonesia Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Injectable Targeted Therapy Market

• 14.1. South Korea Injectable Targeted Therapy Market Overview
• 14.2. South Korea Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Injectable Targeted Therapy Market

• 15.1. Western Europe Injectable Targeted Therapy Market Overview
• 15.2. Western Europe Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Injectable Targeted Therapy Market

• 16.1. UK Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Injectable Targeted Therapy Market

• 17.1. Germany Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Injectable Targeted Therapy Market

• 18.1. France Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Injectable Targeted Therapy Market

• 19.1. Italy Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Injectable Targeted Therapy Market

• 20.1. Spain Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Injectable Targeted Therapy Market

• 21.1. Eastern Europe Injectable Targeted Therapy Market Overview
• 21.2. Eastern Europe Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Injectable Targeted Therapy Market

• 22.1. Russia Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Injectable Targeted Therapy Market

• 23.1. North America Injectable Targeted Therapy Market Overview
• 23.2. North America Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Injectable Targeted Therapy Market

• 24.1. USA Injectable Targeted Therapy Market Overview
• 24.2. USA Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Injectable Targeted Therapy Market

• 25.1. Canada Injectable Targeted Therapy Market Overview
• 25.2. Canada Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Injectable Targeted Therapy Market

• 26.1. South America Injectable Targeted Therapy Market Overview
• 26.2. South America Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Injectable Targeted Therapy Market

• 27.1. Brazil Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Injectable Targeted Therapy Market

• 28.1. Middle East Injectable Targeted Therapy Market Overview
• 28.2. Middle East Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Injectable Targeted Therapy Market

• 29.1. Africa Injectable Targeted Therapy Market Overview
• 29.2. Africa Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Injectable Targeted Therapy Market Competitive Landscape And Company Profiles

• 30.1. Injectable Targeted Therapy Market Competitive Landscape
• 30.2. Injectable Targeted Therapy Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Injectable Targeted Therapy Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi SA
• 31.3. Novartis AG
• 31.4. AstraZeneca plc
• 31.5. Bristol-Myers Squibb Company
• 31.6. GlaxoSmithKline plc
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Gilead Sciences Inc.
• 31.10. Regeneron Pharmaceuticals Inc.
• 31.11. Biogen Inc.
• 31.12. Eisai Co. Ltd.
• 31.13. Genentech Inc.
• 31.14. Beigene Ltd.
• 31.15. Agenus Inc.

32. Global Injectable Targeted Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Injectable Targeted Therapy Market

34. Recent Developments In The Injectable Targeted Therapy Market

35. Injectable Targeted Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Injectable Targeted Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Injectable Targeted Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Injectable Targeted Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer